Increased Drug Competition: Lower Prices, Easier Access to Medicines.
This act aims to facilitate the market entry of cheaper generic drugs. It limits the ability of pharmaceutical companies to use patents and trade secrets to block competition, potentially leading to lower drug prices and increased access for citizens.
Key points
Facilitates the market entry of cheaper generic drug alternatives.
Limits pharmaceutical companies' ability to block competition using patents.
Potential for lower drug prices and increased patient access.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.